Table 8. Stage-specific overall survival for mixed adenoneuroendocrine carcinoma.
| Overall survival | Stage I | Stage II | Stage III | Stage IV |
|---|---|---|---|---|
| 1-year OS | – | 96.6% | 86.4% | 75% |
| 2-year OS | 100% | 96.6% | 79.7% | 41.3% |
| 3-year OS | 100% | 96.6% | 79.7% | 26.5% |
| 4-year OS | – | 85.2% | 53.2% | 26.5% |